New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

20

Janssen and Amgen Combine for Regulatory Win in Multiple Myeloma

Janssen Pharmaceutical and Amgen received another regulatory win for Darzalex Faspro (daratumumab and hyaluronidase-fihj) as the U.S. Food and Drug Administration approved the drug in combination with Amgen’s Kyprolis (carfilzomib) and dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.